BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12750294)

  • 1. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
    Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3, a novel binding partner of beta-catenin.
    Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
    Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
    Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
    Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
    Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
    Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
    Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
    Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
    Rios-Doria J; Kuefer R; Ethier SP; Day ML
    Cancer Res; 2004 Oct; 64(20):7237-40. PubMed ID: 15492240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
    Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P
    Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT; Morin PJ
    Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin.
    Hlubek F; Jung A; Kotzor N; Kirchner T; Brabletz T
    Cancer Res; 2001 Nov; 61(22):8089-93. PubMed ID: 11719433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
    Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
    Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
    Mariadason JM; Bordonaro M; Aslam F; Shi L; Kuraguchi M; Velcich A; Augenlicht LH
    Cancer Res; 2001 Apr; 61(8):3465-71. PubMed ID: 11309309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
    Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
    Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.